Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
57.60-0.21 (-0.36%)
At close: 4:00PM EDT
57.74 +0.14 (+0.24%)
After hours: 07:55PM EDT
Advertisement
Sign in to post a message.
  • G
    Garrett
    Bloomberg News is now reporting that BMY will tender all of its shares of Acceleron in the Merck acquisition. The tender offer price is $180, and BMY owns 11.5% of XLRN. BMY will receive $1.3 BILLION plus it retains rights to XLRN's top drugs including REBLOZYL and Sotatercept which could be a blockbluster medication.
  • j
    jim
    $SLS conversation
    Nps Licensing 30 days, 4, Billion dollar Catalysts in the next 69 days $BMY $MRK $roche End Stage Ovarian Cancer and Mesothelioma Combination readouts - First time results will show Patients Surviving Beyond best available treatments. Intl Headlines> IMO + AML Phase 3 Fda review just +/- 5.5 months 1,000% -2,500% Gains coming for this Baby Bio. Be holding every bag you can carry.
    LMk if you have any questions.
    Bullish
  • R
    Rick
    Is there news today that caused this to be down? Looks like several pharma companies are down today. What gives?
  • A
    Alex
    Bristol Myers interested in buying Aurinia, aothet 4-6 billion hole again?
  • J
    Jabberwonky
    At some point I will have to pity buy this, maybe at $48. It has to go up one day, lol.
  • R
    Real Immuno Investor 10
    $SLS conversation
    Partnerships in place with $mrk $bmy $roche - strongest cash position ever in co history, Nps licensing imminent - share price will be doubling Tripling or Quadrupling in less than 90 days. T Cell Activation Combined with Checkpoint Inhibitors for Ovarian and Mesothelioma End Stage Patients, results set to exceed BAT.
    Bullish
  • M
    Michael
    BMY getting ready to spend $4Billion plus for Aurinia. Again making enriching everyone except BMY shareholders. Aurinia shares jumped 27% today. In the past 8 years next to no one has seen 27% appreciation in BMY shares. Most are at brek even or a loss.
  • S
    Sam
    Can someone please explain why this is going down on good news...?
  • v
    vlad
    Not buying bmy at this point is insanity. Look at rsi. Look at history. Look at the future. The company is fine, the dividend is good, the growth prospects are more than decent.
  • C
    Cubs 99
    BMY 5 year trend = 16%, while S&P 500 did 108%. Not including dividends of course. Incredible.
  • a
    anthony
    Tip ranks survey of 8 analysts over the past 3 months has moved consensus from a moderate buy to a strong buy. Average price target is $75.57 with a high of $85.00, and a low of $68.00.. even at the low, that is greater than a 20% upside with a 5% yield, so greater than 25% total return. Not too shabby a potential performance.
  • K
    K.R
    Going buy AUPH. Stock worth owning now
  • j
    jim
    $SLS conversation
    4, Billion dollar Catalysts in the next 70 days $BMY $MRK $roche End Stage Ovarian Cancer and Mesothelioma Combination readouts - First time results will show Patients Surviving Beyond best available treatments. Intl Headlines> IMO + AML Phase 3 Fda review just +/- 5.5 months 1,000% -2,500% Gains coming for this Baby Bio. Be holding every bag you can carry.
    LMk if you have any questions.
    Bullish
  • D
    Demetrios
    Cannot believe my eyes that this stock is up today. Been quite a roller coaster ride with BMY. I am hoping this ship turns around because it’s a winner in my opinion. One of the best pharma companies but it’s stock price doesn’t reflect it.
  • C
    Carefree
    Time to start a position if you don’t own. This is a solid opportunity with a company at a 12 month low.
  • D
    Demetrios
    BMY should put itself up for sale. C’mon PFE buy this dog out and save me the heartache of seeing my investment in this company go down on a daily basis.
  • D
    Demetrios
    Is there any way someone can buy BMY out. This is the only way us suffering shareholders can maybe make some type of money for holding for the last decade. This company is just a dog with fleas. All I can say is wow!!!
  • F
    Franklin
    Executive management should stand tall and proud.
  • j
    jim
    $SLS conversation
    4, Billion dollar Catalysts in the next 70 days $BMY $MRK $roche End Stage Ovarian Cancer and Mesothelioma Combination readouts - First time results will show Patients Surviving Beyond best available treatments. Intl Headlines> IMO + AML Phase 3 Fda review just +/- 5.5 months 1,000% -2,500% Gains coming for this Baby Bio. Be holding every bag you can carry.
    LMk if you have any questions.
    Bullish
  • j
    jim
    $SLS conversation
    4, Billion dollar Catalysts in the next 70 days $BMY $MRK $roche End Stage Ovarian Cancer and Mesothelioma Combination readouts - First time results will show Patients Surviving Beyond best available treatments. Intl Headlines> IMO + AML Phase 3 Fda review just +/- 5.5 months 1,000% -2,500% Gains coming for this Baby Bio. Be holding every bag you can carry.
    LMk if you have any questions.
    Bullish
Advertisement
Advertisement